In addition, MG severity did not interact with pathological type for CD19+ (FCD19 = 1.140, PCD19 = 0.350) and CD20+ (FCD20 = 0.991, PCD19 = 0.452) populations and CD19+/CD20+ ratios (FCD19/CD20 = 0.372, PCD19/CD20 = 0.931) (Table S5). Here, CD19 is linked to myasthenia gravis.